Active	Status	Sponsor type	Region	Phase	Filter
18 Active 1 Inactive 19 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Sidana, Abhinav
NCT05790213: Focal Prostate Ablation With Androgen Deprivation and Novel Hormonal Therapy for Intermediate Risk Prostate Cancer	Suspended	2	57	US	Apalutamide Oral Product, Androgen Deprivation Therapy (ADT), Focal Therapy	University of Chicago, Janssen, LP	Prostate Cancer	04/26	04/28
LEGEND study, NCT04752722: LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve	Recruiting	1/2	222	Canada, US	EG-70 (phase 1), Phase 1, EG-70 (phase 2), Phase 2	enGene, Inc.	Superficial Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ	06/25	05/27
VAPOR 2, NCT05683691: Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer	Active, not recruiting	N/A	400	US	Vanquish System	Francis Medical Inc.	Prostate Cancer	04/27	04/29
Pinto, Jayat
No trials found